Item 2.02 Results of Operations and Financial Condition.
On
None of the information furnished in Item 2.02 or Exhibit 99.1 hereto shall be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the information furnished in this report shall be incorporated by reference in any filing under the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Exhibit 99.1 Press Release, datedJanuary 25, 2023 , reportingElevance Health, Inc. financial results for the quarter endedDecember 31, 2022 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) FORWARD-LOOKING STATEMENTS
This document contains certain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. Forward-looking statements
reflect our views about future events and financial performance and are
generally not historical facts. Words such as "expect," "feel," "believe,"
"will," "may," "should," "anticipate," "intend," "estimate," "project,"
"forecast," "plan" and similar expressions are intended to identify
forward-looking statements. These statements include, but are not limited to:
financial projections and estimates and their underlying assumptions; statements
regarding plans, objectives and expectations with respect to future operations,
products and services; and statements regarding future performance. Such
statements are subject to certain risks and uncertainties, many of which are
difficult to predict and generally beyond our control, that could cause actual
results to differ materially from those expressed in, or implied or projected
by, the forward-looking statements. You are cautioned not to place undue
reliance on these forward-looking statements that speak only as of the date
hereof. You are also urged to carefully review and consider the various risks
and other disclosures discussed in our reports filed with the
--------------------------------------------------------------------------------
ventures and strategic alliances; possible impairment of the value of our
intangible assets if future results do not adequately support goodwill and other
intangible assets; possible restrictions in the payment of dividends from our
subsidiaries and increases in required minimum levels of capital; our ability to
repurchase shares of our common stock and pay dividends on our common stock due
to the adequacy of our cash flow and earnings and other considerations; the
potential negative effect from our substantial amount of outstanding
indebtedness and the risk that increased interest rates or market volatility
could impact our access to or further increase the cost of financing; a
downgrade in our financial strength ratings; the effects of any negative
publicity related to the health benefits industry in general or us in
particular; events that may negatively affect our licenses with the
--------------------------------------------------------------------------------
© Edgar Online, source